Premature Aging

Premature Aging means getting older faster than usual. This can cause changes in your skin, hair, and other body parts that normally happen later in life.

Condition

What people with Premature Aging report

Every report comes from a Lived member, sent anonymously.

Have you tried Sunscreen for Premature Aging?

NameHow it went

About Premature Aging

What It Is

Premature aging describes changes normally associated with getting older, such as hair loss, aged-looking skin, hardened arteries or cataracts, appearing far earlier in life than expected. In medicine, the term usually refers to a small group of rare genetic conditions called progeroid syndromes, in which a change in a single gene speeds up several aging-related processes at once. These conditions affect some parts of the body much more than others, so they are not simply ordinary aging on fast forward. The two best known are Hutchinson-Gilford progeria syndrome (HGPS) and Werner syndrome. Children with HGPS usually look healthy at birth, then grow and gain weight slowly and, within the first years of life, lose their hair and the fat under their skin and develop aged-looking skin and stiff joints. Their intelligence and development of skills such as walking are not affected. The most serious problem is severe hardening of the arteries beginning in childhood, which greatly raises the chance of a heart attack or stroke at a young age. Werner syndrome, sometimes called adult progeria, typically shows itself after puberty. Teenagers miss their growth spurt, and from the twenties people develop graying and thinning hair, a hoarse voice, and thin, hardened skin, followed by cataracts in both eyes, diabetes, thinning bones, slow-healing skin ulcers and a higher risk of hardened arteries and certain cancers. These syndromes are very different from looking older than one's age because of sun damage or smoking. Those skin changes are common and largely preventable, and they do not carry the body-wide effects of a progeroid syndrome.

Causes & Risk Factors

Each progeroid syndrome is caused by changes (variants) in a specific gene. HGPS comes from a variant in the LMNA gene, which carries the instructions for lamin A, a protein that holds the cell's nucleus in shape. The altered protein, called progerin, makes the nucleus unstable and causes cells to wear out and die early. HGPS almost always arises from a new variant in the child, with no family history, so it is not caused by anything the parents did. It is extremely rare, reported in about 1 in 4 million newborns. Werner syndrome comes from variants in the WRN gene, which helps the cell repair and copy its DNA. It is inherited in an autosomal recessive pattern: a person is affected only when they receive a nonworking copy of the gene from each parent, and the parents, who each carry one copy, usually have no signs of it. It affects about 1 in 200,000 people in the United States and is more common in Japan. Other rare progeroid conditions involve LMNA or a related gene, ZMPSTE24, and they differ widely in how early they start and how severe they are. Diet, stress and other everyday factors do not cause these syndromes. In people without a genetic condition, however, sunlight is a major cause of skin aging, and smoking adds wrinkles that increase with how much and how long someone has smoked.

How It's Diagnosed

A diagnosis usually starts with a recognizable combination of features rather than any single one. For HGPS, that means a young child whose growth and weight gain have slowed, together with hair loss, loss of fat under the skin, a characteristic facial appearance and stiff joints. For Werner syndrome, clues include short stature after a missing teenage growth spurt, early graying, cataracts in both eyes in early adulthood, and diabetes or bone thinning at an unusually young age. Early gray hair or wrinkles on their own do not suggest a progeroid syndrome. Genetic testing confirms the diagnosis by finding the responsible variant: in LMNA (or sometimes ZMPSTE24) for HGPS and related conditions, and in both copies of WRN for Werner syndrome. Confirmation matters because these conditions can look alike at first but differ in their course, how they are inherited and how they are treated; the one approved medicine, for example, works only for certain genetic types. Genetic counseling can explain what the result means for brothers, sisters and future children, which is especially relevant for Werner syndrome because it is inherited from both parents.

Treatment Options

There is no cure for any progeroid syndrome. Treatment aims to slow the most dangerous effects where a medicine exists and to manage each complication as it appears. For HGPS, lonafarnib (Zokinvy) is the only medicine approved by the US Food and Drug Administration (FDA). It is a capsule taken twice a day that blocks an enzyme the body needs to build up progerin, the faulty protein behind the disease. It is approved for children 12 months and older above a minimum body size, to reduce the risk of dying from HGPS, and for certain closely related conditions involving the same protein pathway. In studies, treated children lived on average about 2.5 years longer over up to 11 years of follow-up than similar untreated children. That evidence comes from comparing treated children with earlier records rather than from a randomized trial, and the medicine does not reverse features already present. Vomiting, diarrhea, nausea and loss of appetite are common, along with tiredness and infections. Lonafarnib also interacts with many medicines (including some common cholesterol-lowering statins) and can affect heart rhythm, so treatment involves a review of every other medicine, heart rhythm tracings (ECGs), regular blood tests and eye exams. It is not approved for Werner syndrome or other progeroid syndromes and is not expected to work in them. Werner syndrome has no disease-specific medicine, so care focuses on its complications. Diabetes is very common and tends to involve strong resistance to insulin even in people who are thin; metformin and a class of diabetes medicines called thiazolidinediones are effective for controlling blood sugar. Skin ulcers, often on the lower legs and feet, heal poorly, so treating calluses and pressure points early is an important way to prevent them, and surgery is sometimes needed to close a wound. Because cancer and hardened arteries are the leading causes of death in Werner syndrome, ongoing follow-up with the care team is part of long-term treatment. For skin that looks older than expected without an underlying syndrome, sun protection and stopping smoking help prevent further change. Many products claim to reverse skin aging, but the FDA has approved only a few for sun-damaged or aging skin, so a dermatologist can help sort out which treatments are worth considering.

What to Expect

The outlook depends heavily on which syndrome a person has. In HGPS, artery disease advances through childhood, and in records of untreated children, median survival was about 14.6 years, with heart and blood vessel disease the most common cause of death. Lonafarnib has added some time on average. Because HGPS does not affect intelligence or milestones such as walking, children can usually learn and take part in daily life alongside their peers, with adjustments for their small size and stiff joints. Care tends to involve regular visits to several specialists, since problems with the heart, blood vessels, joints and nutrition can change over time. Werner syndrome unfolds over adulthood. People usually live into their late forties or early fifties, and cancer and hardened arteries are the most common causes of death. Daily life is often shaped by managing diabetes, changes in vision, painful foot calluses and slow-healing leg ulcers that can limit walking, and reduced fertility. Ongoing follow-up allows these problems to be found and treated earlier. Both syndromes are rare enough that many doctors have never cared for someone with one, so people and families often end up coordinating care across specialists and keeping their own record of tests and treatments.

When to Seek Help

Talk to a doctor, and ask whether a genetics referral makes sense, if a young child is growing and gaining weight far more slowly than expected along with hair loss, tightening skin or stiff joints, or if a teenager or young adult develops several aging-related problems together, such as cataracts, diabetes and early graying with skin changes. For someone with Werner syndrome, contact the care team about any new sore, wound or painful callus on the feet or lower legs, since these heal slowly and are easier to treat early. For someone taking lonafarnib, contact the prescriber about new vision changes or stomach side effects that make it hard to eat or drink. In a child or adult with HGPS, chest pain, sudden weakness or numbness on one side, trouble speaking or a sudden severe headache can mean a heart attack or stroke even at a young age, so call 911.

Questions to Ask Your Doctor

  1. 1.Which condition, if any, explains these changes, and what genetic testing would confirm it?
  2. 2.What does this diagnosis mean for brothers, sisters or future children?
  3. 3.Is lonafarnib or a clinical trial an option, and what benefit and monitoring should we realistically expect?
  4. 4.Which complications should we watch for now, and which specialists should be part of regular care?

Last reviewed • Oct 2026

Educational content, not medical advice.